Based on this knowledge, our demonstration that what differentiates between HNSCC patients responding or not responding to therapies is their relative frequencies of CD8+CD28+ and CD8+CD28− T cells, is of relevance. Here, CD28 is linked to head and neck squamous cell carcinoma.